A 4-week, multicentre, randomized, double-blind, placebo controlled, double dummy, parallel group study, to assess the effect of lumiracoxib 100 mg o.d. and ibuprofen 600 mg t.i.d on 24-hour blood pressure profile and on urinary excretions of eicosanoids, in osteoarthritis patients with controlled hypertension
Phase of Trial: Phase IV
Latest Information Update: 28 Nov 2007
At a glance
- Drugs Ibuprofen; Lumiracoxib
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Adverse reactions
- 28 Nov 2007 Status change from recruiting to completed.
- 07 Feb 2007 New trial record.